[Ga-68]-PNT6555 for Soft Tissue Sarcoma
This trial will study two different treatments in people with solid tumors that have too much of a protein called FAP. The goal is to find out if they are safe and what the best dose is.
- Soft Tissue Sarcoma
- Colorectal Cancer
- Skin Cancer
- Bile Duct Cancer
- Head and Neck Squamous Cell Carcinoma
- Pancreatic Cancer
- Esophageal Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is it possible for me to participate in this clinical experiment?
"This medical study is enrolling 30 individuals aged 18 to 80 who have colorectal carcinoma. Furthermore, eligibility criteria includes: the use of two acceptable forms of contraception for 31 weeks (females) or 18 weeks (males), adenocarcinoma of the pancreas, high-grade soft tissue sarcoma excluding chordoma, platelet counts over 120 000/ mm^3 at dosing with transfusion allowed except during first dose administration, [esophageal cancer](https://www.withpower.com/clinical-trials/esophageal-cancer) in form of squamous cell carcinoma or adenocarcinoma but not gastroesophageal junction cancer, melan"
What potential hazards are associated with [Ga-68]-PNT6555 for patients?
"As this is an early-phase trial with only minimal data available regarding efficacy and safety, [Ga-68]-PNT6555 received a score of 1."
Are there any remaining slots available to prospective participants in this experiment?
"The current status of the clinical trial, as per information on clinicaltrials.gov, is actively recruiting participants. This medical experiment was first advertised on July 13th 2022 with the most recent update being September 21st 2022."
Are there any age restrictions for individuals looking to participate in this trial?
"Adults aged 18 to 80 are eligible for enrollment in this trial. There is also a wealth of research available pertaining to minors and seniors; there are 223 studies on those under the age of 18, and 2010 related to elderly individuals over 65 years old."
What is the current participant count for this experiment?
"Affirmative. Clinicaltrials.gov reveals that this clinical trial, which was initially posted on July 13th 2022, is actively recruiting for participants. The study aims to recruit a total of 30 patients from 3 different sites."